MarketPeel
Insider Trading Intelligence
GW

Gregory S. Wessels

APRE
SVP, CHIEF COMMERCIAL OFFICER · APREA THERAPEUTICS, INC. · CIK 0001824615
FILING MIX · LIFETIME100%/0%
BUYS
3
SELLS
0
TOTAL VALUE
$0
COMPANIES
1
ACTIVE SINCE
Sep 2020
HOLDINGS NOW
16,000
AVG SELL PX
TRADE KIND
SHOWING 3 / 3
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
No backtest data available for Gregory S. Wessels. Backtests are computed for purchase (P) and sale (S) transactions with resolvable price history.
Holdings over time
APRE · 16,000 shares · as of Feb 25, 2021
016,50033,00049,50066,0002021SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2020
2020
2021
FLOW · 3 buys / 0 sellsCOVERAGE · 3 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILED
APRE
APREA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
66,00066,000Feb 25, 2021Mar 1, 2021
APRE
APREA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
16,00016,000Feb 25, 2021Mar 1, 2021
APRE
APREA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
14,70014,700Sep 16, 2020Sep 18, 2020
Other insiders · APRE
Loading peer insiders…
About this filer
CIK 0001824615
ROLE
SVP, Chief Commercial Officer
PRIMARY
APRE
COMPANIES
1
ACTIVE SINCE
Sep 2020
MARKETPEEL · /INSIDER/0001824615DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback